Screener
Amgen AMGN Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Amgen’s reported figures.
Based on trailing twelve months.
The source filing: Amgen’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 7:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000318154-26-000057
FAQ
- What is Amgen's return on equity?
- Amgen (AMGN) reported return on equity of 101.3% in Q1 2026.
- How has Amgen's return on equity changed year-over-year?
- Amgen's return on equity decreased by 4.1% year-over-year, from 105.7% to 101.3%.
- What is the long-term trend for Amgen's return on equity?
- Over 5 years (2020 to 2025), Amgen's return on equity has grown at a 6.9% compound annual growth rate (CAGR), from 76.1% to 106.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Amgen's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude